Annual report
4361.TEDINET S100SXGS
Period2022-12-01 → 2023-11-30
Filed2024-02-22
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.6bn | 2022-12-01 → 2023-11-30 | Cons. | Net sales |
| Revenue | ¥8.4bn | 2021-12-01 → 2022-11-30 | Cons. | Net sales |
| Revenue | ¥7.9bn | 2020-12-01 → 2021-11-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.6bn | 2019-12-01 → 2020-11-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.5bn | 2018-12-01 → 2019-11-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥354m | 2022-12-01 → 2023-11-30 | Cons. | Operating income |
| Operating income | ¥294m | 2021-12-01 → 2022-11-30 | Cons. | Operating income |
| Ordinary income | ¥345m | 2022-12-01 → 2023-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥303m | 2021-12-01 → 2022-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥386m | 2020-12-01 → 2021-11-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥83m | 2019-12-01 → 2020-11-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥187m | 2018-12-01 → 2019-11-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥342m | 2022-12-01 → 2023-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥283m | 2021-12-01 → 2022-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥256m | 2022-12-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥219m | 2021-12-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥281m | 2020-12-01 → 2021-11-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥59m | 2019-12-01 → 2020-11-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥147m | 2018-12-01 → 2019-11-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥256m | 2022-12-01 → 2023-11-30 | Cons. | Profit loss |
| Net income | ¥219m | 2021-12-01 → 2022-11-30 | Cons. | Profit loss |
| Total assets | ¥8.3bn | at 2023-11-30 | Cons. | Assets |
| Total assets | ¥8.3bn | at 2022-11-30 | Cons. | Assets |
| Total assets | ¥7.9bn | at 2021-11-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥7.2bn | at 2020-11-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥7.3bn | at 2019-11-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.7bn | at 2023-11-30 | Cons. | Liabilities |
| Total liabilities | ¥5.9bn | at 2022-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥2.6bn | at 2023-11-30 | Cons. | Net assets |
| Net assets / equity | ¥2.4bn | at 2022-11-30 | Cons. | Net assets |
| Net assets / equity | ¥2.3bn | at 2021-11-30d | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2020-11-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.9bn | at 2019-11-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.0bn | at 2023-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥911m | at 2022-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.0bn | at 2023-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥911m | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2021-11-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥883m | at 2020-11-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥397m | at 2019-11-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥470m | 2022-12-01 → 2023-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥21m | 2021-12-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥785m | 2020-12-01 → 2021-11-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥654m | 2019-12-01 → 2020-11-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥286m | 2018-12-01 → 2019-11-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥370m | 2022-12-01 → 2023-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥243m | 2021-12-01 → 2022-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥246m | 2020-12-01 → 2021-11-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥392m | 2019-12-01 → 2020-11-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥907m | 2018-12-01 → 2019-11-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥21m | 2022-12-01 → 2023-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥162m | 2021-12-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥119m | 2020-12-01 → 2021-11-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥222m | 2019-12-01 → 2020-11-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥349m | 2018-12-01 → 2019-11-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥209.88 | 2022-12-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥179.75 | 2021-12-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥230.99 | 2020-12-01 → 2021-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.73 | 2019-12-01 → 2020-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥120.48 | 2018-12-01 → 2019-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,167.14 | at 2023-11-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,980.62 | at 2022-11-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,850.07 | at 2021-11-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,619.73 | at 2020-11-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,600.24 | at 2019-11-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 31.6% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.0% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.5% | at 2021-11-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.4% | at 2020-11-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.7% | at 2019-11-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 10.1% | 2022-12-01 → 2023-11-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.4% | 2021-12-01 → 2022-11-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.3% | 2020-12-01 → 2021-11-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.0% | 2019-12-01 → 2020-11-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.7% | 2018-12-01 → 2019-11-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 166 | at 2023-11-30 | Cons. | Number of employees |
| Employees | 171 | at 2022-11-30 | Cons. | Number of employees |
| Employees | 165 | at 2021-11-30d | Cons. | Number of employees |
| Employees | 173 | at 2020-11-30d | Cons. | Number of employees |
| Employees | 164 | at 2019-11-30d | Cons. | Number of employees |
| Revenue | ¥8.4bn | 2022-12-01 → 2023-11-30 | Standalone | Net sales |
| Revenue | ¥8.2bn | 2021-12-01 → 2022-11-30 | Standalone | Net sales |
| Revenue | ¥7.7bn | 2020-12-01 → 2021-11-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.5bn | 2019-12-01 → 2020-11-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.4bn | 2018-12-01 → 2019-11-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥341m | 2022-12-01 → 2023-11-30 | Standalone | Operating income |
| Operating income | ¥249m | 2021-12-01 → 2022-11-30 | Standalone | Operating income |
| Ordinary income | ¥333m | 2022-12-01 → 2023-11-30 | Standalone | Ordinary income |
| Ordinary income | ¥262m | 2021-12-01 → 2022-11-30 | Standalone | Ordinary income |
| Ordinary income | ¥329m | 2020-12-01 → 2021-11-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥59m | 2019-12-01 → 2020-11-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥162m | 2018-12-01 → 2019-11-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥330m | 2022-12-01 → 2023-11-30 | Standalone | Income before income taxes |
| Profit before tax | ¥243m | 2021-12-01 → 2022-11-30 | Standalone | Income before income taxes |
| Net income | ¥246m | 2022-12-01 → 2023-11-30 | Standalone | Profit loss |
| Net income | ¥185m | 2021-12-01 → 2022-11-30 | Standalone | Profit loss |
| Net income | ¥242m | 2020-12-01 → 2021-11-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥40m | 2019-12-01 → 2020-11-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥128m | 2018-12-01 → 2019-11-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥8.1bn | at 2023-11-30 | Standalone | Assets |
| Total assets | ¥8.2bn | at 2022-11-30 | Standalone | Assets |
| Total assets | ¥7.8bn | at 2021-11-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.1bn | at 2020-11-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.2bn | at 2019-11-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.7bn | at 2023-11-30 | Standalone | Liabilities |
| Total liabilities | ¥5.9bn | at 2022-11-30 | Standalone | Liabilities |
| Net assets / equity | ¥2.5bn | at 2023-11-30 | Standalone | Net assets |
| Net assets / equity | ¥2.2bn | at 2022-11-30 | Standalone | Net assets |
| Net assets / equity | ¥2.1bn | at 2021-11-30d | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2020-11-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.9bn | at 2019-11-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥834m | at 2023-11-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥683m | at 2022-11-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥201.87 | 2022-12-01 → 2023-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥151.85 | 2021-12-01 → 2022-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥198.64 | 2020-12-01 → 2021-11-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.47 | 2019-12-01 → 2020-11-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥104.9 | 2018-12-01 → 2019-11-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥50 | 2022-12-01 → 2023-11-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2021-12-01 → 2022-11-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2020-12-01 → 2021-11-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2019-12-01 → 2020-11-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2018-12-01 → 2019-11-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,015.67 | at 2023-11-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,847.66 | at 2022-11-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,758.24 | at 2021-11-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,573.45 | at 2020-11-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,571.92 | at 2019-11-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 30.2% | at 2023-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.6% | at 2022-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.6% | at 2021-11-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.9% | at 2020-11-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.4% | at 2019-11-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 10.5% | 2022-12-01 → 2023-11-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.4% | 2021-12-01 → 2022-11-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2020-12-01 → 2021-11-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.1% | 2019-12-01 → 2020-11-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2018-12-01 → 2019-11-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,220,000 | at 2023-11-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,220,000 | at 2022-11-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,220,000 | at 2021-11-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,220,000 | at 2020-11-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,220,000 | at 2019-11-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 160 | at 2023-11-30 | Standalone | Number of employees |
| Employees | 166 | at 2022-11-30 | Standalone | Number of employees |
| Employees | 159 | at 2021-11-30d | Standalone | Number of employees |
| Employees | 167 | at 2020-11-30d | Standalone | Number of employees |
| Employees | 159 | at 2019-11-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceutical Productsreportable segment | capex | 2022-12-01 → 2023-11-30 | ¥314m |
| Pharmaceutical Productsreportable segment | depreciation | 2022-12-01 → 2023-11-30 | ¥406m |
| Pharmaceutical Productsreportable segment | employees | at 2023-11-30 | 165 pure |
| Pharmaceutical Productsreportable segment | revenue | 2022-12-01 → 2023-11-30 | ¥8.6bn |
| Pharmaceutical Productsreportable segment | revenue external | 2022-12-01 → 2023-11-30 | ¥8.6bn |
| Pharmaceutical Productsreportable segment | segment assets | at 2023-11-30 | ¥8.3bn |
| Pharmaceutical Productsreportable segment | segment profit | 2022-12-01 → 2023-11-30 | ¥323m |
| Real Estate Leasingreportable segment | employees | at 2023-11-30 | 1 pure |
| Real Estate Leasingreportable segment | revenue | 2022-12-01 → 2023-11-30 | ¥38m |
| Real Estate Leasingreportable segment | revenue external | 2022-12-01 → 2023-11-30 | ¥38m |
| Real Estate Leasingreportable segment | segment assets | at 2023-11-30 | ¥71m |
| Real Estate Leasingreportable segment | segment profit | 2022-12-01 → 2023-11-30 | ¥31m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-12-01 → 2023-11-30 | ¥314m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-12-01 → 2023-11-30 | ¥406m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-12-01 → 2023-11-30 | ¥8.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-12-01 → 2023-11-30 | ¥8.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-11-30 | ¥8.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-12-01 → 2023-11-30 | ¥354m |
| Pharmaceutical Productsreportable segment | capex | 2021-12-01 → 2022-11-30 | ¥382m |
| Pharmaceutical Productsreportable segment | depreciation | 2021-12-01 → 2022-11-30 | ¥396m |
| Pharmaceutical Productsreportable segment | revenue | 2021-12-01 → 2022-11-30 | ¥8.3bn |
| Pharmaceutical Productsreportable segment | revenue external | 2021-12-01 → 2022-11-30 | ¥8.3bn |
| Pharmaceutical Productsreportable segment | segment assets | at 2022-11-30 | ¥8.3bn |
| Pharmaceutical Productsreportable segment | segment profit | 2021-12-01 → 2022-11-30 | ¥263m |
| Real Estate Leasingreportable segment | revenue | 2021-12-01 → 2022-11-30 | ¥38m |
| Real Estate Leasingreportable segment | revenue external | 2021-12-01 → 2022-11-30 | ¥38m |
| Real Estate Leasingreportable segment | segment assets | at 2022-11-30 | ¥71m |
| Real Estate Leasingreportable segment | segment profit | 2021-12-01 → 2022-11-30 | ¥30m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-12-01 → 2022-11-30 | ¥382m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-12-01 → 2022-11-30 | ¥396m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-12-01 → 2022-11-30 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-12-01 → 2022-11-30 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-11-30 | ¥8.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-12-01 → 2022-11-30 | ¥294m |
| Pharmaceutical Productsreportable segment | employees | at 2023-11-30 | 159 pure |
| Real Estate Leasingreportable segment | employees | at 2023-11-30 | 1 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,441
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in investment activities | CurrentYearDuration | -370243000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YearDuration | － | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYearDuration | 200000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YearDuration | 500000000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYearDuration | － | JPY |
| Repayment of long term loans payable fin cf | Prior1YearDuration | -587216000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYearDuration | -100801000 | JPY |
| Repayments of lease obligations fin cf | Prior1YearDuration | -14117000 | JPY |
| Repayments of lease obligations fin cf | CurrentYearDuration | -17723000 | JPY |
| Purchase of treasury stock fin cf | Prior1YearDuration | -134000 | JPY |
| Purchase of treasury stock fin cf | CurrentYearDuration | － | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -60700000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -60617000 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | -162168000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | 20858000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YearDuration | 17043000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYearDuration | 12351000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | -408858000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | 132896000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 1319778000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 910919000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 910919000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 1043816000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 1 | |
| Shipping expenses and storage fee selling expenses | Prior1YearDuration | 211809000 | JPY |
| Shipping expenses and storage fee selling expenses | CurrentYearDuration | 202700000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration | 494000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration | 386000 | JPY |
| Directors compensations sga | Prior1YearDuration | 88621000 | JPY |
| Directors compensations sga | CurrentYearDuration | 73873000 | JPY |
| Employee payrolls and allowances general and administrative expenses | Prior1YearDuration | 367878000 | JPY |
| Employee payrolls and allowances general and administrative expenses | CurrentYearDuration | 364648000 | JPY |
| Legal welfare expenses sga | Prior1YearDuration | 27332000 | JPY |
| Legal welfare expenses sga | CurrentYearDuration | 26723000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 244961000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 240396000 | JPY |
| Depreciation research and development expenses | Prior1YearDuration | 64629000 | JPY |
| Depreciation research and development expenses | CurrentYearDuration | 65898000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 59686000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 31791000 | JPY |
| Provision for directors bonuses sga | Prior1YearDuration | 16500000 | JPY |
| Provision for directors bonuses sga | CurrentYearDuration | 16200000 | JPY |
| Provision for directors retirement benefits sga | Prior1YearDuration | 14200000 | JPY |
| Provision for directors retirement benefits sga | CurrentYearDuration | 8985000 | JPY |
| Depreciation sga | Prior1YearDuration | 13462000 | JPY |
| Depreciation sga | CurrentYearDuration | 15800000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 244961000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 240396000 | JPY |
| Write downs of inventories | Prior1YearDuration | 7920000 | JPY |
| Write downs of inventories | CurrentYearDuration | -23025000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |